Markus Hauser Email & Phone Number

California, United States

San Francisco, California, United States

• Established a new team with 4 functional leaders (Market Research & Competitive Intelligence, Advanced Analytics, Forecasting, Reporting, Data Strategy and Operations). The team supports the growth of the company across therapeutic areas and expanding geographies.• Architected a data/analytics technology and services platform in preparation for the launch of the company’s first commercial product. Obtained the necessary investment, selected and onboarded key data assets, systems, and… Show more • Established a new team with 4 functional leaders (Market Research & Competitive Intelligence, Advanced Analytics, Forecasting, Reporting, Data Strategy and Operations). The team supports the growth of the company across therapeutic areas and expanding geographies.• Architected a data/analytics technology and services platform in preparation for the launch of the company’s first commercial product. Obtained the necessary investment, selected and onboarded key data assets, systems, and service vendors to support launch efforts.• As key member of the commercial team, involved in board discussions related to the commercial future of the company such as pipeline/LCM planning, partnering, and go-to-market strategy. Led wargames to educate on and work through complex, multi-indication development. and pricing challenges.• Member of the data governance, AI, and diversity/inclusion councils as well as the forecast committee. Show less

San Francisco Bay Area

• Assembled an experienced team of industry veterans to establish and grow the company from $0 to several $MM in revenues by developing and bringing to market a Commercial AI and Machine Learning platform for bio-pharma companies. The platform is proving instrumental in turning around/delivering rapid growth for launch and mature brands across the globe.• Attracted 20+ biotech/pharma clients in the US, Europe, and Asia to implement innovative commercial analytics and execution… Show more • Assembled an experienced team of industry veterans to establish and grow the company from $0 to several $MM in revenues by developing and bringing to market a Commercial AI and Machine Learning platform for bio-pharma companies. The platform is proving instrumental in turning around/delivering rapid growth for launch and mature brands across the globe.• Attracted 20+ biotech/pharma clients in the US, Europe, and Asia to implement innovative commercial analytics and execution capabilities and crack some of the toughest revenue/ profitability problems for retail, specialty, and rare disease brands. • Established global partnerships with PwC, Itochu, Tableau, and Symphony Health.• Secured IP from MIT, patents/trademarks, and financing from private investors. Show less

Greater Boston Area

Responsible for advanced analytics, commercial effectiveness, forecasting, commercial information management for the entire product portfolio including MS, Hemophilia and pipeline products. • Drove commercial effectiveness programs delivering over $200MM in incremental revenue p.a., designed and implemented several sales force automation/operations applications and trained field forces in their effective use, initiated a collaboration with MIT to implement an analytics engine to drive… Show more Responsible for advanced analytics, commercial effectiveness, forecasting, commercial information management for the entire product portfolio including MS, Hemophilia and pipeline products. • Drove commercial effectiveness programs delivering over $200MM in incremental revenue p.a., designed and implemented several sales force automation/operations applications and trained field forces in their effective use, initiated a collaboration with MIT to implement an analytics engine to drive marketing, sales, managed market and patient service ROI.• Defined organizational growth strategy for therapeutic area expansion going from 700 to 1,500 FTEs, re-designed sales forces and sales processes, championed cutting edge adherence technologies, delivered strategic and operational forecasts for MS and Hemophila markets and products, improved quality, availability, and integration of commercial data. Show less

Munich Area, Germany

Developed marketing strategy for Tysabri delivering a 20% market share gain, managed commercial advisory boards, liaised with field force, developed support systems for physicians to manage benefit-risk ratio for their patients, partnered with Silvia Lawry Center to develop an evidence based patient progression assessment to decide on therapy switch, initiated a program to empower patients to find optimal setting of care.

Zürich Area, Switzerland

Managed commercial aspects of ex-US markets (e.g. product launch, biosimilar strategy, pricing and reimbursement, investment ROI), responsible for international Key Opinion Leader relationships (IMSEF - International Multiple Sklerosis Expert Forum) and forum of country managers, responsible for $6MM in annual spend.Responsible for developing pipeline products from a commercial point of view and for evaluating in-licensing opportunities, therapeutic expansion strategy, biosimilar… Show more Managed commercial aspects of ex-US markets (e.g. product launch, biosimilar strategy, pricing and reimbursement, investment ROI), responsible for international Key Opinion Leader relationships (IMSEF - International Multiple Sklerosis Expert Forum) and forum of country managers, responsible for $6MM in annual spend.Responsible for developing pipeline products from a commercial point of view and for evaluating in-licensing opportunities, therapeutic expansion strategy, biosimilar defense and offense, member of the founding team of Eidetica (now Bioepis)- a biosimilar company, ex-US neurology, cardiovascular, dermatology, and rheumatology pre-marketing. Show less

New York

• Defined positioning, messaging, KOL, and patient support strategies to leverage new formulation and clinical trial data and successfully re-launch a $1BN drug in the USA.• Developed financial model and strategic recommendation for generic defense strategy for biologic. Project deliverable included the support of a negotiation process.• Isolated cost and growth drivers, generated strategic alternatives and solutions addressing national and regional drug and medical service utilization/… Show more • Defined positioning, messaging, KOL, and patient support strategies to leverage new formulation and clinical trial data and successfully re-launch a $1BN drug in the USA.• Developed financial model and strategic recommendation for generic defense strategy for biologic. Project deliverable included the support of a negotiation process.• Isolated cost and growth drivers, generated strategic alternatives and solutions addressing national and regional drug and medical service utilization/ pricing issues to identify cost saving opportunities of 20% of total healthcare cost for Fortune 50 company.• Developed strategy to redirect “cost” based negotiations with PBMs to value based contracting. Managed a team of 3 associates to determine target products/customers, design adherence program, define product performance guarantees, and identify pilot partners.• Worked with business development group of large pharma company to assess opportunity of offering cost effective pharmacy benefit administration to small employers.• Leveraged NDC’s Dynamic Claims Analyzer to help top 3 pharmaceutical company build capability to optimize rebates offered to PBMs and Health Plans. Show less

Greater Boston Area

• Developed commercial infrastructure for biotech companies: Managed a team of consultants to design commercial infrastructure scenarios, ramp up plans, and partnering strategies for companies with successful phase II/III trials and commercialization aspirations. • Defined portfolio investment strategy: Created a portfolio strategy for a top 5 pharma co. Coached 10 brand managers in CNS, CV and RESP to identify annual sales growth in excess of €100M, evaluated co-promotion options to… Show more • Developed commercial infrastructure for biotech companies: Managed a team of consultants to design commercial infrastructure scenarios, ramp up plans, and partnering strategies for companies with successful phase II/III trials and commercialization aspirations. • Defined portfolio investment strategy: Created a portfolio strategy for a top 5 pharma co. Coached 10 brand managers in CNS, CV and RESP to identify annual sales growth in excess of €100M, evaluated co-promotion options to achieve sales targets, and implemented an up-sized sales force of +150 reps. • Designed go-to-market-strategy: Managed 5 consultants to analyze the regulatory environment, competitors, customer needs, and delivery channels in EU5 for the launch of an oncology product. Show less

Frankfurt Am Main Area, Germany

• Worked in big 5 pharmaceutical markets in Europe.• Developed commercial infrastructure for the launch of 3 biotech companies across Europe.• Sales force and marketing optimization in Germany, UK, France, Spain, and Italy.• Global best practices for after-sales service for top German car manufacturer.

AdPilot measures the impact of off-line mass media advertising and price discounts on consumer purchases, enabling retailers, OTC, and consumer packaged goods companies to target the most responsive consumers.• Financing: Raised $0.5MM of $1.2MM from private investors.• Business Development: Created marketing and sales strategy, including market segmentation and developed sales-maximizing pricing model, co-managed successful transition from concept to market launch.• Methodology:… Show more AdPilot measures the impact of off-line mass media advertising and price discounts on consumer purchases, enabling retailers, OTC, and consumer packaged goods companies to target the most responsive consumers.• Financing: Raised $0.5MM of $1.2MM from private investors.• Business Development: Created marketing and sales strategy, including market segmentation and developed sales-maximizing pricing model, co-managed successful transition from concept to market launch.• Methodology: Co-authored 3 patent applications for the measurement of print and TV advertising impact on purchases and direct marketing programs. Managed 4 professionals to implement the analysis methodology Show less

Post Doc / Sen. Scholar, Organizational Behavior

Management Department and GLOBE Project GLOBE comprises of 170 researchers in 62 nations investigating how national cultures affect.

Dr. Oec. Publ. (Phd), Strategic Management & Leadership, Summa Cum Laude

Institute for Research in Business Administration, University of Zurich, Zurich, Switzerland Major: Strategic Management and Org..

Lic Oec. Publ. (Ba & Mba), Banking And Marketing, Summa Cum Laude

Major: Finance and Banking. Master thesis: Prognosis of Returns and Diversification Effects of International Stock Portfolios.